Microbiology Testing Market by Product [Instrument, Reagent & Kit, Consumable], Technology [Traditional (Manual Counting, Culture), Rapid (Nucleic Acid, Viability)], End User [Pharma, Biotech, Food, Water, Environmental Testing]-Global Forecast to 2031

icon1
USD 10.09 BN
MARKET SIZE, 2030
icon2
CAGR 5.3%
(2025-2030)
icon3
379
REPORT PAGES
icon4
246
MARKET TABLES

OVERVIEW

microbiology-testing-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global microbiology testing market, valued at USD 7.45 billion in 2025, stood at USD 7.79 billion in 2026 and is projected to advance at a resilient CAGR of 5.3% from 2026 to 2031, culminating in a forecasted valuation of USD 10.09 billion by the end of the period. The major factors driving the growth of the market include the rising need for contamination control, rising government regulations in various sectors and continuous innovation in microbiology testing. The rising need for quality assurance in the food, water, pharmaceutical and environmental industries as well as innovations in testing technology are also fueling the growth of the market. The market faces challenges such as the high cost of advanced testing technology and doubts about the accuracy of results from low-cost testing technology. The opportunities in the market include the rising need for rapid and automated testing technology, the rising focus on product safety and government regulations and innovations in sustainable and efficient testing technology.

KEY TAKEAWAYS

  • BY PRODUCT
    The reagents & kits segment is projected to dominate the market during the forecast period.
  • BY TECHNOLOGY
    The Traditional Microbiology Methods (TMM) accounted for the largest market share in 2025 with 63.0% of the shares.
  • BY PATHOGEN TYPE
    The bacterial segment accounted for the largest market share in 2025.
  • BY END USER
    The Pharmaceutical & Biotech Companies segment is registered to have the fastest growth in the forecasted period of 5.7%
  • BY REGION
    The North America region accounted for the largest market share in 2025 with 38.6% of the shares.
  • COMPETITIVE LANDSCAPE
    The global microbiology testing market is steadily growing, driven by strategic partnerships and strong R&D investments. Key players like bioMérieux (France), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Charles River Laboratories (US), and Neogen Corporation (US) and others leverage diverse product portfolios and innovation to expand globally through collaborations, acquisitions, and new product launches.

The microbiology testing market is driven by the growing focus on contamination control, product safety, and regulatory compliance across industries. Advancements in testing technologies have improved accuracy and efficiency, while increasing production volumes and quality assurance requirements in food, water, pharmaceuticals, and environmental applications continue to support market growth.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The microbiology testing market is heavily impacted by shifts in the patterns of industrial demand and quality control measures. The manufacturing units in the pharmaceutical, biotech, food and beverage, water and environmental industries are the key end users of microbiology testing solutions. Shifts in manufacturing processes the use of advanced testing technology or supply chain disruptions in testing products have a direct effect on the volume of testing and the end user demand for microbiology testing solutions. This in turn, affects the demand for microbiology testing solutions and the growth strategies of market players.

microbiology-testing-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Technological advancements in rapid microbiology testing
  • Increased funding for R&D
RESTRAINTS
Impact
Level
  • Complexity in testing techniques
  • High Capital investments and low cost benefit ratio
OPPORTUNITIES
Impact
Level
  • Popularity of digital and automated testing platforms
  • Technological advancements in testing industry
CHALLENGES
Impact
Level
  • Operational barriers
  • Increasing cost of procuring microbiology testing equipment

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Technological advancements in rapid microbiology testing

Microbiology testing has moved from traditional culture based testing to rapid microbiological testing technologies to facilitate faster detection, increased efficiency and enhanced contamination control. Although traditional testing is effective it is challenged by the long testing times and the need for human intervention. Rapid testing technologies overcome these challenges through automation, real time monitoring and sophisticated detection systems, which reduce testing times and reliance on human resources. The cost effectiveness, reduced resource requirements and applicability to quality control and quality assurance in food, water, pharmaceutical, biotech, environmental and cosmetic industries have contributed to the increased adoption of rapid microbiology testing technologies. Continued developments in analytical instrumentation and detection systems have broadened the applications of rapid microbiology testing in industrial quality control systems.

Restraint: Complexity in testing techniques

Test results can be affected by technical and operational challenges, especially when samples contain interfering substances, chemical residues or very low levels of contamination. These factors can prevent microbes from being detected, leading to false negative results and potential quality failures which may lead to confusion in the results. This is important to the industry where contamination can trigger product recalls, regulatory penalties or long term damage to brand reputation that can affect the end user. Meeting strict detection limits, validation requirements and regulatory standards also make microbiology tests both labor intensive and costly for the end user.

Opportunity: Popularity of digital and automated testing platforms

The convergence of AI analytics, IoT capable biosensors and automated lab solutions is rapidly changing microbiology testing from a periodic lab based analysis to a real time continuous monitoring process. IoT biosensors and AI analytics enable early contamination detection in food processing, water treatment plants and industrial sites, allowing for quicker action and better compliance. Solutions like IoT refrigeration monitoring, VOC sensors for spoilage detection and intelligent packaging solutions with built in gas sensors improve safety, minimize waste and optimize operational expenses.

Challenge: Operational barriers

Operational barriers are still a major issue in microbiology testing where the processes are labor intensive and time consuming. This makes them prone to errors and reduces their capacity and the lack of standardization in these settings makes it difficult to standardize and audit them. Infrastructure issues, old equipment, poor system integration and shortages of reagents and consumables in the market are some of the factors that hinder the adoption of modern microbiology testing technology.

MICROBIOLOGY TESTING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides microbiology systems for contamination detection. Improves accuracy and supports regulatory compliance.
Supplies instruments and reagents for microbiology testing. Enables high-throughput and reliable testing workflows.
Offers culture media and microbiology reagents. Ensures standardized and consistent quality control.
Delivers microbiology tools and automated systems. Reduces manual errors and improves efficiency.
Provides rapid tests for food and environmental monitoring. Enables early detection and routine contamination control.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The microbiology testing market ecosystem comprises a network of manufacturers, distributors, and development partners working together to ensure adequate microbial control in the acquired products. Manufacturers drive innovation by microbiology testing products. Distributors, logistics companies and group purchasing organizations provide for the timely distribution and availability of products in the market. Pharmaceutical & biotech companies, food & beverage companies, environmental & water testing and cosmetics & personal care companies are the major end users who adopt microbiology testing products to enhance patient safety. Strategic collaborations, technological developments and investments are increasing the accessibility of microbiology testing products.

microbiology-testing-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

microbiology-testing-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Microbiology Testing Market, By Product

The microbiology testing market is divided into three main segments based on product: instruments, reagents & kits, and consumables. Due to their frequent use, broad applicability throughout routine and specialized testing, and crucial function in sample preparation, microbe detection, and identification, reagents and kits comprise the largest section of the microbiology testing market. Reagents and kits are utilized continuously throughout testing workflows, creating steady demand, in contrast to equipment, which are capital purchases. Contamination monitoring, quality control, and regulatory compliance in pharmaceuticals, biotechnology, food, water, and environmental testing are just a few of the many uses for them. Furthermore, the growing use of standardized, ready-to-use kits enhances testing accuracy, lessens operator reliance, and facilitates quicker turnaround times, all of which contribute to this segment's supremacy.

Microbiology Testing Market, By Technology

The traditional microbiology techniques occupy the largest market in the technology segment, as they have been proven reliable and accepted by the regulatory bodies and have been in use for a long time. The traditional techniques include culture-based techniques and manual counting, which are regarded as gold standards for microbial detection and identification. The traditional techniques are cost effective, require less infrastructure, and are well understood by laboratory personnel, making them the dominant techniques despite the availability of rapid and advanced techniques. The regulatory guidelines and standard operating procedures are also based on the traditional techniques, making them the dominant techniques in the market.

Microbiology Testing Market, By Pathogen Type

the bacterial segment accounted for the largest share in the microbiology testing market in 2025. Bacteria have the largest market share in the pathogen type market for microbiology testing because of their significant impact on the safety and quality of products. Bacterial contamination is one of the significant concerns in the food and beverage industry, water treatment and manufacturing industry. Bacterial testing is critical in ensuring that the products meet the safety standards, detecting spoilage and preventing contamination during the manufacturing process.

Microbiology Testing Market, By End User

Based on end user, the microbiology testing market is divided into pharmaceutical & biotech companies, food & beverage companies, environmental & water testing, cosmetic & personal-care companies, and other end users. Among these end users, the pharmaceutical & biotech companies held the largest market share in 2025 for microbiology testing. Pharmaceutical and biotechnology companies represent the largest end user segment in the microbiology testing market due to their strict regulatory requirements, high sensitivity to contamination risks, and continuous need for quality assurance across manufacturing and research processes. Microbial testing is essential at multiple stages, including raw material validation, in-process monitoring, finished product release, and stability testing, driving high testing volumes

REGION

Asia Pacific is projected to be the fastest-growing market of the surgical gowns and drapes market during the forecast period

Asia Pacific represents the most rapidly expanding market in the microbiology testing market and this is attributed to a number of key factors, such as the rapid industrialization of the region, increased investments in the healthcare sector and the growing concern for contamination control in different industries. The region is witnessing a substantial rise in the food and beverage industry, water treatment and environmental monitoring and all these sectors demand extensive microbiological testing to ensure safety and regulatory compliance. Moreover, the improved infrastructure of the healthcare sector along with growing awareness regarding food safety and public health is also contributing to the demand for testing solutions.

microbiology-testing-market Region

MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX

bioMérieux (France) (Star) is an important player in the microbiology testing industry because of its broad range of high quality diagnostic and microbiology products. The company’s strong emphasis on innovation, strict regulatory compliance and efforts to meet the growing demands of microbiology testing have made it a reliable source in the industry. bioMérieux has an established global presence, strong customer base and ongoing focus on research and development which enable it to provide cutting edge microbiology testing systems, reagents and consumables. QIAGEN (Netherlands) (Emerging leader) is one of the most important emerging market players recognized for its innovative approach to offer high quality microbiology testing.

microbiology-testing-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size Value in 2026 (Value) USD 7.79 Billion
Market Forecast in 2031 (Value) USD 10.09 Billion
Growth Rate CAGR of 5.3% from 2026 to 2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Million)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Product (Instruments (Incubators, Microscopes, Colony Counters, Mass Spectrometers, Automated Culture Systems, Other Instruments), Reagents & Kits, Consumables), By Technology (Traditional Microbiology Methods (Culture Methods, Microscopy Methods, Manual Counting Methods, Staining Techniques, Other Traditional Microbiology Methods), Rapid Microbiology Methods (Growth-Based Rapid Microbiology Testing, Cellular Component Based Rapid Microbiology Testing, Nucleic Acid-Based Rapid Microbiology Testing, Viability Based Rapid Microbiology Testing)), By Pathogen Type (Bacterial, Viral, Fungal, Other Pathogens), By End User (Pharmaceutical & Biotech Companies, Food & Beverage Companies, Environmental & Water Testing, Cosmetics & Personal-Care Companies, Other End Users)
Regional Scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

WHAT IS IN IT FOR YOU: MICROBIOLOGY TESTING MARKET REPORT CONTENT GUIDE

microbiology-testing-market Content Guide

RECENT DEVELOPMENTS

  • November 2025 : Thermo Fisher Scientific introduced the Thermo Scientific SureTect Beverage Spoilage Multiplex qPCR Assay, developed in collaboration with Coca-Cola Europacific Partners. Integrated into the SureTect PCR System, the assay enables early, accurate detection of beverage spoilage organisms, supporting proactive quality control across beverage production workflows.
  • February 2025 : bioMérieux launched GENE-UP TYPER, an innovative diagnostic solution for food industries to rapidly analyze the root cause of contamination of Listeria monocytogenes
  • February 2025 : Merck’s Life Science business has entered into a global distribution and collaboration agreement with Rapid Micro Biosystems, expanding worldwide access to the Growth Direct platform. The partnership broadens Merck’s global sales channels while creating opportunities for collaboration across supply chain efficiencies, service offerings, and joint product development.
  • June 2023 : Becton, Dickinson and Company opened a new USD 4.69 million (€4 million) research and development facility in Blackrock, Dublin, and announced an additional USD 35.18million (€30 million) investment to expand its manufacturing facility in Enniscorthy, Wexford.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
30
2
EXECUTIVE SUMMARY
 
 
 
 
 
34
3
PREMIUM INSIGHTS
 
 
 
 
 
38
4
MARKET OVERVIEW
Technological advances and strategic moves drive rapid microbiology testing market growth amidst rising recalls.
 
 
 
 
 
41
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
TECHNOLOGICAL ADVANCEMENTS IN RAPID MICROBIOLOGY TESTING
 
 
 
 
 
 
4.2.1.2
INCREASED FUNDING FOR R&D
 
 
 
 
 
 
4.2.1.3
RISING FOOD RECALLS DUE TO NON-COMPLIANT FOOD PRODUCTS
 
 
 
 
 
 
4.2.1.4
RISING DEMAND FROM COSMETICS & PERSONAL CARE INDUSTRY
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
COMPLEXITY IN TESTING TECHNIQUES
 
 
 
 
 
 
4.2.2.2
HIGH CAPITAL INVESTMENTS AND LOW COST-BENEFIT RATIO
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
POPULARITY OF DIGITAL AND AUTOMATED TESTING PLATFORMS
 
 
 
 
 
 
4.2.3.2
TECHNOLOGICAL ADVANCEMENTS IN TESTING INDUSTRY
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
OPERATIONAL BARRIERS
 
 
 
 
 
 
4.2.4.2
INCREASING COST OF PROCURING MICROBIOLOGY TESTING EQUIPMENT
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
 
4.3.1
UNMET NEEDS IN MICROBIOLOGY TESTING MARKET
 
 
 
 
 
 
4.3.2
WHITE SPACE OPPORTUNITIES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
 
4.4.1
INTERCONNECTED MARKETS
 
 
 
 
 
 
4.4.2
CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
 
 
 
 
 
 
 
4.5.1
KEY MOVES AND STRATEGIC FOCUS
 
 
 
 
5
INDUSTRY TRENDS
Navigate shifting industry dynamics with insights on pricing, competitive forces, and macroeconomic impacts.
 
 
 
 
 
52
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC INDICATORS
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING, BY PRODUCT
 
 
 
 
 
 
5.6.2
AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS, BY KEY PLAYER
 
 
 
 
 
 
5.6.3
AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS, BY REGION
 
 
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.7.1
IMPORT SCENARIO (HS CODE 3822)
 
 
 
 
 
 
5.7.2
EXPORT SCENARIO (HS CODE 3822)
 
 
 
 
 
5.8
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.10
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.11
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.11.1
YOUNGS SEAFOOD ACCELERATED FOOD TESTING WITH VIDAS
 
 
 
 
 
 
5.11.2
RAPID MICROBIOLOGICAL METHOD CASE STUDY FOR ADVANCED THERAPY MEDICINAL PRODUCTS
 
 
 
 
 
 
5.11.3
RAPID DETECTION METHOD OF BACTERIAL PATHOGENS IN SURFACE WATERS AND NEW RISK INDICATOR FOR WATER PATHOGENIC POLLUTION
 
 
 
 
 
5.12
IMPACT OF 2025 US TARIFFS ON MICROBIOLOGY TESTING MARKET
 
 
 
 
 
 
 
 
5.12.1
INTRODUCTION
 
 
 
 
 
 
5.12.2
KEY TARIFF RATES
 
 
 
 
 
 
5.12.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.12.4
KEY IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
 
5.12.4.1
NORTH AMERICA
 
 
 
 
 
 
5.12.4.2
EUROPE
 
 
 
 
 
 
5.12.4.3
ASIA PACIFIC
 
 
 
 
 
5.12.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.12.5.1
PHARMACEUTICAL & BIOTECH COMPANIES
 
 
 
 
 
 
5.12.5.2
FOOD & BEVERAGE COMPANIES
 
 
 
 
 
 
5.12.5.3
ENVIRONMENTAL & WATER TESTING
 
 
 
 
 
 
5.12.5.4
COSMETICS & PERSONAL CARE COMPANIES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations are revolutionizing microbiology testing with advanced diagnostics and robust patent growth.
 
 
 
 
 
71
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1
AUTOMATED MULTIPLEX PCR SYSTEMS
 
 
 
 
 
 
6.1.2
BIOSENSORS
 
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.2.1
FOOD & WATER SAFETY MONITORING TOOLS
 
 
 
 
 
 
6.2.2
ANTIMICROBIAL RESISTANCE TESTING
 
 
 
 
 
6.3
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.4
PATENT ANALYSIS
 
 
 
 
 
 
 
6.5
FUTURE APPLICATION
 
 
 
 
 
 
6.6
IMPACT OF AI/GENERATIVE AI ON MICROBIOLOGY TESTING MARKET
 
 
 
 
 
 
 
 
6.6.1
INTRODUCTION
 
 
 
 
 
 
6.6.2
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.6.3
USE CASE
 
 
 
 
 
 
 
6.6.3.1
ADOPTION OF GEN AI BY CARBCONNECT TO ACHIEVE ACCURACY AND CONSISTENCY IN DIAGNOSTICS
 
 
 
 
 
6.6.4
EVOLVING ADJACENT ECOSYSTEM THROUGH ADOPTION OF GEN AI
 
 
 
 
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
Navigate global eco-friendly regulations to boost compliance in microbiology testing markets.
 
 
 
 
 
78
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
 
7.2.1
ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN MICROBIOLOGY TESTING
 
 
 
 
 
 
 
7.2.1.1
ECO-FRIENDLY INITIATIVES
 
 
 
 
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock market potential by navigating stakeholder influence and overcoming adoption barriers in key industries.
 
 
 
 
 
83
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
BUYING CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
 
 
8.5.1
REVENUE POTENTIAL
 
 
 
 
 
 
8.5.2
COST DYNAMICS
 
 
 
 
 
 
8.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS
 
 
 
 
9
MICROBIOLOGY TESTING MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 50 Data Tables
 
 
 
 
 
88
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
INSTRUMENTS
 
 
 
 
 
 
 
9.2.1
WIDESPREAD ADOPTION OF AUTOMATED AND HIGH-THROUGHPUT LABORATORY INSTRUMENTS TO SUPPORT MICROBIOLOGY TESTING DEMAND
 
 
 
 
 
 
9.2.2
INCUBATORS
 
 
 
 
 
 
 
9.2.2.1
CONTROLLED ENVIRONMENTAL CONDITIONS TO ENABLE RELIABLE MICROBIAL GROWTH AND DETECTION
 
 
 
 
 
9.2.3
MICROSCOPES
 
 
 
 
 
 
 
9.2.3.1
DIRECT VISUALIZATION AND MORPHOLOGICAL ANALYSIS OF MICROORGANISMS
 
 
 
 
 
9.2.4
COLONY COUNTERS
 
 
 
 
 
 
 
9.2.4.1
ACCURATE ENUMERATION OF MICROBIAL COLONIES TO SUPPORT QUALITY ASSURANCE
 
 
 
 
 
9.2.5
MASS SPECTROMETERS
 
 
 
 
 
 
 
9.2.5.1
RAPID AND ACCURATE MICROBIAL IDENTIFICATION THROUGH ADVANCED MASS SPECTROMETRY METHODS
 
 
 
 
 
9.2.6
AUTOMATED CULTURE SYSTEMS
 
 
 
 
 
 
 
9.2.6.1
HIGH-THROUGHPUT SYSTEMS SUPPORTING STANDARDIZED MICROBIOLOGY WORKFLOWS
 
 
 
 
 
9.2.7
OTHER INSTRUMENTS
 
 
 
 
 
9.3
REAGENTS & KITS
 
 
 
 
 
 
 
9.3.1
HIGH RECURRING DEMAND FOR STANDARDIZED AND READY-TO-USE REAGENTS & KITS TO SUPPORT MARKET GROWTH
 
 
 
 
 
9.4
CONSUMABLES
 
 
 
 
 
 
 
9.4.1
CONSISTENT HIGH-VOLUME CONSUMPTION OF DISPOSABLE LABORATORY SUPPLIES TO FUEL ROUTINE MICROBIOLOGY TESTING MARKET
 
 
 
 
10
MICROBIOLOGY TESTING MARKET: VOLUME ANALYSIS
 
 
 
 
 
116
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
US: VOLUME OF PHARMA INCUBATOR INSTALLED BASE
 
 
 
 
 
11
MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 60 Data Tables
 
 
 
 
 
117
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
TRADITIONAL MICROBIOLOGY METHODS (TMM)
 
 
 
 
 
 
 
11.2.1
WIDESPREAD REGULATORY ACCEPTANCE AND COST-EFFECTIVENESS TO SUPPORT CONTINUED ADOPTION
 
 
 
 
 
 
11.2.2
CULTURE METHODS
 
 
 
 
 
 
 
11.2.2.1
CONTINUED RELIANCE ON CULTURE-BASED TECHNIQUES TO SUPPORT ROUTINE MICROBIOLOGY TESTING
 
 
 
 
 
11.2.3
MICROSCOPY METHODS
 
 
 
 
 
 
 
11.2.3.1
RAPID PRELIMINARY MICROBIAL SCREENING TO SUPPORT CONTAMINATION INVESTIGATIONS
 
 
 
 
 
11.2.4
MANUAL COUNTING METHODS
 
 
 
 
 
 
 
11.2.4.1
REGULATORY ACCEPTANCE OF PLATE COUNT TECHNIQUES TO MAINTAIN WIDESPREAD USAGE
 
 
 
 
 
11.2.5
STAINING TECHNIQUES
 
 
 
 
 
 
 
11.2.5.1
LOW-COST AND EFFECTIVE MICROBIAL DIFFERENTIATION METHODS TO SUPPORT QUALITY CONTROL
 
 
 
 
 
11.2.6
OTHER TRADITIONAL MICROBIOLOGY METHODS
 
 
 
 
 
11.3
RAPID MICROBIOLOGY METHODS (RMM)
 
 
 
 
 
 
 
11.3.1
RAPID MICROBIOLOGY METHODS ENABLE FASTER CONTAMINATION DETECTION AND IMPROVED TESTING EFFICIENCY
 
 
 
 
 
 
11.3.2
GROWTH-BASED RAPID MICROBIOLOGY TESTING
 
 
 
 
 
 
 
11.3.2.1
GROWING DEMAND FOR GROWTH-BASED RAPID MICROBIOLOGY TESTING TO DRIVE MARKET GROWTH
 
 
 
 
 
11.3.3
CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING
 
 
 
 
 
 
 
11.3.3.1
HIGH LEVEL OF SENSITIVITY, ACCURACY, AND SPECIFICITY ASSOCIATED WITH THIS METHOD TO BOOST MARKET
 
 
 
 
 
11.3.4
NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING
 
 
 
 
 
 
 
11.3.4.1
HIGH ACCURACY ASSOCIATED WITH NUCLEIC ACID-BASED METHODS TO FAVOR MARKET GROWTH
 
 
 
 
 
11.3.5
VIABILITY-BASED RAPID MICROBIOLOGY TESTING
 
 
 
 
 
 
 
11.3.5.1
NEAR REAL-TIME DETECTION AND IMPROVED ACCURACY TO DRIVE DEMAND
 
 
 
12
MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 21 Data Tables
 
 
 
 
 
152
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
BACTERIAL
 
 
 
 
 
 
 
12.2.1
WIDESPREAD OCCURRENCE OF BACTERIAL CONTAMINATION ACROSS INDUSTRIES TO SUPPORT MARKET DOMINANCE
 
 
 
 
 
12.3
VIRAL
 
 
 
 
 
 
 
12.3.1
INCREASING FOCUS ON VIRAL SAFETY AND ENVIRONMENTAL SURVEILLANCE TO DRIVE SEGMENT GROWTH
 
 
 
 
 
12.4
FUNGAL
 
 
 
 
 
 
 
12.4.1
RISING INCIDENCE OF YEAST AND MOLD CONTAMINATION TO FUEL TESTING DEMAND
 
 
 
 
 
12.5
OTHER PATHOGENS
 
 
 
 
 
13
MICROBIOLOGY TESTING MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 26 Data Tables
 
 
 
 
 
162
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
PHARMACEUTICAL & BIOTECH COMPANIES
 
 
 
 
 
 
 
13.2.1
STRINGENT GMP AND CONTAMINATION CONTROL REQUIREMENTS TO DRIVE TESTING DEMAND
 
 
 
 
 
13.3
FOOD & BEVERAGE COMPANIES
 
 
 
 
 
 
 
13.3.1
STRINGENT FOOD SAFETY REGULATIONS AND QUALITY CONTROL TO SUPPORT MARKET GROWTH
 
 
 
 
 
13.4
ENVIRONMENTAL & WATER TESTING
 
 
 
 
 
 
 
13.4.1
GROWING FOCUS ON WATER SAFETY AND ENVIRONMENTAL MONITORING TO DRIVE DEMAND
 
 
 
 
 
13.5
COSMETICS & PERSONAL CARE COMPANIES
 
 
 
 
 
 
 
13.5.1
MICROBIAL SAFETY AND PRODUCT STABILITY REQUIREMENTS TO SUPPORT MARKET GROWTH
 
 
 
 
 
13.6
OTHER END USERS
 
 
 
 
 
14
MICROBIOLOGY TESTING MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 14 Countries | 93 Data Tables.
 
 
 
 
 
177
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
NORTH AMERICA
 
 
 
 
 
 
 
14.2.1
US
 
 
 
 
 
 
 
14.2.1.1
INCREASING ADOPTION OF TECHNOLOGICALLY ADVANCED PRODUCTS IN US TO FAVOR MARKET GROWTH
 
 
 
 
 
14.2.2
CANADA
 
 
 
 
 
 
 
14.2.2.1
FAVORABLE ENVIRONMENT FOR R&D TO DRIVE MARKET
 
 
 
 
14.3
EUROPE
 
 
 
 
 
 
 
14.3.1
GERMANY
 
 
 
 
 
 
 
14.3.1.1
INCREASE IN INVESTMENTS AND FUNDING BY GOVERNMENT TO FUEL MARKET GROWTH
 
 
 
 
 
14.3.2
UK
 
 
 
 
 
 
 
14.3.2.1
HIGH PREVALENCE OF CONTAMINATED FOOD TO DRIVE MARKET
 
 
 
 
 
14.3.3
FRANCE
 
 
 
 
 
 
 
14.3.3.1
RISE IN R&D EXPENDITURE TO FAVOR MARKET GROWTH
 
 
 
 
 
14.3.4
ITALY
 
 
 
 
 
 
 
14.3.4.1
INCREASED ADOPTION OF ADVANCED DIAGNOSTIC TECHNOLOGIES AND GROWING GOVERNMENT HEALTHCARE INVESTMENTS TO DRIVE MARKET
 
 
 
 
 
14.3.5
SPAIN
 
 
 
 
 
 
 
14.3.5.1
WATER MONITORING MANDATE TO BOOST MARKET GROWTH
 
 
 
 
 
14.3.6
REST OF EUROPE
 
 
 
 
 
14.4
ASIA PACIFIC
 
 
 
 
 
 
 
14.4.1
CHINA
 
 
 
 
 
 
 
14.4.1.1
HIGH-PROFILE CONTAMINATION EVENTS AND EXPORT STANDARDS TO PROPEL MARKET
 
 
 
 
 
14.4.2
JAPAN
 
 
 
 
 
 
 
14.4.2.1
STRINGENT SAFETY LAWS AND FOODBORNE OUTBREAKS TO ACCELERATE MARKET
 
 
 
 
 
14.4.3
INDIA
 
 
 
 
 
 
 
14.4.3.1
GROWTH IN PRIVATE AND PUBLIC INVESTMENTS IN HEALTHCARE SYSTEMS TO DRIVE ADOPTION OF MICROBIOLOGY TESTING PRODUCTS
 
 
 
 
 
14.4.4
SOUTH KOREA
 
 
 
 
 
 
 
14.4.4.1
INCREASING DEMAND FOR INFECTION CONTROL PRODUCTS TO SUPPORT MARKET GROWTH
 
 
 
 
 
14.4.5
AUSTRALIA
 
 
 
 
 
 
 
14.4.5.1
INCREASE IN AWARENESS ABOUT ANTIMICROBIAL RESISTANCE TO FUEL MARKET
 
 
 
 
 
14.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
14.5
LATIN AMERICA
 
 
 
 
 
 
 
14.5.1
BRAZIL
 
 
 
 
 
 
 
14.5.1.1
NEED FOR MANUFACTURERS TO COMPLY WITH ANVISA’S RULES TO DRIVE DEMAND
 
 
 
 
 
14.5.2
MEXICO
 
 
 
 
 
 
 
14.5.2.1
EXPANDING MICROBIOLOGY TESTING CAPACITY THROUGH TRADE AND FOOD SAFETY ENFORCEMENT TO DRIVE MARKET
 
 
 
 
 
14.5.3
REST OF LATIN AMERICA
 
 
 
 
 
14.6
MIDDLE EAST & AFRICA
 
 
 
 
 
15
COMPETITIVE LANDSCAPE
Discover how key players and emerging leaders are reshaping market dynamics and strategies.
 
 
 
 
 
227
 
15.1
OVERVIEW
 
 
 
 
 
 
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025
 
 
 
 
 
 
15.3
REVENUE ANALYSIS, 2022–2024
 
 
 
 
 
 
 
15.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
15.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
15.5.1
STARS
 
 
 
 
 
 
15.5.2
EMERGING LEADERS
 
 
 
 
 
 
15.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
15.5.4
PARTICIPANTS
 
 
 
 
 
 
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
15.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
15.5.5.2
REGIONAL FOOTPRINT
 
 
 
 
 
 
15.5.5.3
PRODUCT FOOTPRINT
 
 
 
 
 
 
15.5.5.4
TECHNOLOGY FOOTPRINT
 
 
 
 
 
 
15.5.5.5
END USER FOOTPRINT
 
 
 
 
15.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
15.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
15.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
15.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
15.6.4
STARTING BLOCKS
 
 
 
 
 
 
15.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
15.6.5.1
LIST OF STARTUPS/SMES
 
 
 
 
 
 
15.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
 
 
 
 
15.6.5.2.1
COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
 
 
 
 
 
 
15.6.5.2.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2)
 
 
15.7
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
15.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
15.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
15.9.1
PRODUCT LAUNCHES AND APPROVALS
 
 
 
 
 
 
15.9.2
DEALS
 
 
 
 
 
 
15.9.3
EXPANSIONS
 
 
 
 
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
244
 
16.1
KEY PLAYERS
 
 
 
 
 
 
 
16.1.1
BIOMÉRIEUX
 
 
 
 
 
 
 
16.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
16.1.1.2
PRODUCTS OFFERED
 
 
 
 
 
 
16.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
16.1.1.3.1
PRODUCT LAUNCHES AND APPROVALS
 
 
 
 
 
 
16.1.1.3.2
DEALS
 
 
 
 
16.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
16.1.1.4.1
RIGHT TO WIN
 
 
 
 
 
 
16.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
16.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
16.1.2
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
16.1.3
MERCK KGAA
 
 
 
 
 
 
16.1.4
BECTON, DICKINSON AND COMPANY (BD)
 
 
 
 
 
 
16.1.5
NEOGEN CORPORATION
 
 
 
 
 
 
16.1.6
QIAGEN
 
 
 
 
 
 
16.1.7
BIO-RAD LABORATORIES, INC.
 
 
 
 
 
 
16.1.8
BRUKER
 
 
 
 
 
 
16.1.9
SHIMADZU CORPORATION
 
 
 
 
 
 
16.1.10
CHARLES RIVER LABORATORIES
 
 
 
 
 
 
16.1.11
EUROFINS SCIENTIFIC
 
 
 
 
 
 
16.1.12
IDEXX
 
 
 
 
 
16.2
OTHER PLAYERS
 
 
 
 
 
 
 
16.2.1
HARDY DIAGNOSTICS
 
 
 
 
 
 
16.2.2
CHARM SCIENCES
 
 
 
 
 
 
16.2.3
MICROBIOLOGICS
 
 
 
 
 
 
16.2.4
LIOFILCHEM S.R.L.
 
 
 
 
 
 
16.2.5
R-BIOPHARM
 
 
 
 
 
 
16.2.6
ROMER LABS DIVISION HOLDING
 
 
 
 
 
 
16.2.7
HYGIENA LLC
 
 
 
 
 
 
16.2.8
HIMEDIA LABORATORIES
 
 
 
 
 
 
16.2.9
CONDALAB
 
 
 
 
 
 
16.2.10
E&O LABORATORIES LTD
 
 
 
 
 
 
16.2.11
MAST GROUP LTD.
 
 
 
 
 
 
16.2.12
MEDICAL WIRE & EQUIPMENT
 
 
 
 
 
 
16.2.13
HACH
 
 
 
 
17
RESEARCH METHODOLOGY
 
 
 
 
 
300
 
17.1
RESEARCH DATA
 
 
 
 
 
 
17.2
RESEARCH APPROACH
 
 
 
 
 
 
 
17.2.1
SECONDARY DATA
 
 
 
 
 
 
 
17.2.1.1
KEY SECONDARY SOURCES
 
 
 
 
 
 
17.2.1.2
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
17.2.2
PRIMARY DATA
 
 
 
 
 
 
 
17.2.2.1
PRIMARY SOURCES
 
 
 
 
 
 
17.2.2.2
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
17.2.2.3
KEY INDUSTRY INSIGHTS
 
 
 
 
 
 
17.2.2.4
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
17.3
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
17.3.1
BOTTOM-UP APPROACH
 
 
 
 
 
 
 
17.3.1.1
APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
 
 
 
 
 
 
17.3.1.2
APPROACH 2: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
 
 
 
 
 
 
17.3.1.3
GROWTH FORECAST
 
 
 
 
 
 
17.3.1.4
CAGR PROJECTIONS
 
 
 
 
 
17.3.2
TOP-DOWN APPROACH
 
 
 
 
 
17.4
DATA TRIANGULATION
 
 
 
 
 
 
17.5
MARKET SHARE ASSESSMENT
 
 
 
 
 
 
17.6
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
 
17.6.1
PARAMETRIC ASSUMPTIONS
 
 
 
 
 
17.7
RESEARCH LIMITATIONS
 
 
 
 
 
 
17.8
RISK ASSESSMENT
 
 
 
 
 
18
APPENDIX
 
 
 
 
 
313
 
18.1
DISCUSSION GUIDE
 
 
 
 
 
 
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
18.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
18.4
RELATED REPORTS
 
 
 
 
 
 
18.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
INCLUSIONS AND EXCLUSIONS
 
 
 
 
 
 
TABLE 2
US: FOOD RECALLS IN AND REASONS, 2023
 
 
 
 
 
 
TABLE 3
US: FOOD RECALLS, BY SPECIES, 2023
 
 
 
 
 
 
TABLE 4
TOP INNOVATIONS IN FOOD TESTING TECHNOLOGY
 
 
 
 
 
 
TABLE 5
INTERCONNECTED MARKETS
 
 
 
 
 
 
TABLE 6
KEY MOVES AND STRATEGIC FOCUS
 
 
 
 
 
 
TABLE 7
IMPACT OF PORTER’S FIVE FORCES ON MICROBIOLOGY TESTING MARKET
 
 
 
 
 
 
TABLE 8
GDP PERCENTAGE CHANGE, BY KEY COUNTRIES, 2023-2030
 
 
 
 
 
 
TABLE 9
NORTH AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 10
EUROPE: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 11
ASIA PACIFIC: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 12
LATIN AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 13
MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 14
MICROBIOLOGY TESTING MARKET: ROLE OF COMPANIES IN ECOSYSTEM
 
 
 
 
 
 
TABLE 15
AVERAGE SELLING PRICING TREND OF MICROBIOLOGY TESTING, BY PRODUCT, 2024–2026 (USD)
 
 
 
 
 
 
TABLE 16
AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING, BY KEY PLAYER, 2024–2026 (USD)
 
 
 
 
 
 
TABLE 17
AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS, BY REGION, 2024–2026 (USD)
 
 
 
 
 
 
TABLE 18
IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 19
EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 20
MICROBIOLOGY TESTING MARKET: KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 21
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 22
LIST OF MAJOR PATENTS PERTAINING TO MICROBIOLOGY TESTING MARKET, 2023–2025
 
 
 
 
 
 
TABLE 23
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 24
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 25
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 26
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 27
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 28
GLOBAL STANDARDS IN THE MICROBIOLOGY TESTING MARKET
 
 
 
 
 
 
TABLE 29
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
 
 
 
 
 
 
TABLE 30
KEY BUYING CRITERIA, BY PRODUCT
 
 
 
 
 
 
TABLE 31
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
TABLE 32
MICROBIOLOGY TESTING MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
TABLE 33
MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
KEY INSTRUMENTS IN MICROBIOLOGY TESTING INSTRUMENTS MARKET
 
 
 
 
 
 
TABLE 35
MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
NORTH AMERICA: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
EUROPE: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
ASIA PACIFIC: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
LATIN AMERICA: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
MICROBIOLOGY TESTING INCUBATORS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
NORTH AMERICA: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
EUROPE: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
ASIA PACIFIC: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
LATIN AMERICA: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
MICROSCOPES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
COLONY COUNTERS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
NORTH AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
EUROPE: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
ASIA PACIFIC: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
LATIN AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
NORTH AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
EUROPE: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
ASIA PACIFIC: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
LATIN AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
AUTOMATED CULTURE SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
NORTH AMERICA: AUTOMATED CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
EUROPE: AUTOMATED CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
NORTH AMERICA: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
EUROPE: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
ASIA PACIFIC: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
LATIN AMERICA: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
KEY REAGENTS & KITS IN MICROBIOLOGY TESTING INSTRUMENTS MARKET
 
 
 
 
 
 
TABLE 72
MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
NORTH AMERICA: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
EUROPE: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
ASIA PACIFIC: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
LATIN AMERICA: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
KEY CONSUMABLES IN MICROBIOLOGY TESTING INSTRUMENTS MARKET
 
 
 
 
 
 
TABLE 78
MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
NORTH AMERICA: MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
EUROPE: MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
US: PHARMA INCUBATOR INSTALLED BASE VOLUME, 2024–2031 (UNITS)
 
 
 
 
 
 
TABLE 84
MICROBIOLOGY TESTING TECHNOLOGY MARKET, BY TECHNOLOGY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
TYPES OF TECHNOLOGIES USED IN VARIOUS TRADITIONAL MICROBIOLOGY METHODS (TMM)
 
 
 
 
 
 
TABLE 86
TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
NORTH AMERICA: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
EUROPE: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
ASIA PACIFIC: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
LATIN AMERICA: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
CULTURE METHODS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
NORTH AMERICA: CULTURE METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
EUROPE: CULTURE METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
ASIA PACIFIC: CULTURE METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
LATIN AMERICA: CULTURE METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
MICROSCOPY METHODS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
NORTH AMERICA: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
EUROPE: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
ASIA PACIFIC: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
LATIN AMERICA: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
MANUAL COUNTING METHODS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
NORTH AMERICA: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
EUROPE: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
ASIA PACIFIC: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
LATIN AMERICA: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
STAINING TECHNIQUES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
NORTH AMERICA: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
EUROPE: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
ASIA PACIFIC: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
LATIN AMERICA: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
NORTH AMERICA: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
EUROPE: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
ASIA PACIFIC: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
LATIN AMERICA: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY METHODS (RMM)
 
 
 
 
 
 
TABLE 118
RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
NORTH AMERICA: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
EUROPE: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
ASIA PACIFIC: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
LATIN AMERICA: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
NORTH AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
EUROPE: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
ASIA PACIFIC: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
LATIN AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
NORTH AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
EUROPE: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
ASIA PACIFIC: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
LATIN AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
NORTH AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
EUROPE: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
ASIA PACIFIC: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
LATIN AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
NORTH AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
EUROPE: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
ASIA PACIFIC: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
LATIN AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
BACTERIAL TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
NORTH AMERICA: BACTERIAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
EUROPE: BACTERIAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
ASIA PACIFIC: BACTERIAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
LATIN AMERICA: BACTERIAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
VIRAL TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
NORTH AMERICA: VIRAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
EUROPE: VIRAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
ASIA PACIFIC: VIRAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
LATIN AMERICA: VIRAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
FUNGAL TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
NORTH AMERICA: FUNGAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
EUROPE: FUNGAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
ASIA PACIFIC: FUNGAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
LATIN AMERICA: FUNGAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
OTHER PATHOGEN TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
NORTH AMERICA: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
EUROPE: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
ASIA PACIFIC: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
LATIN AMERICA: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
EUROPE: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
EUROPE: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
EUROPE: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
EUROPE: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
EUROPE: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY END USERS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
US: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
US: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
US: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
US: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
CANADA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
CANADA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
CANADA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
CANADA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
EUROPE: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
EUROPE: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
EUROPE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
EUROPE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
EUROPE: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
GERMANY: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
GERMANY: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
GERMANY: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
GERMANY: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
UK: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
UK: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
UK: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
UK: MICROBIOLOGY TESTING MARKET, BY END USERS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
FRANCE: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
FRANCE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
FRANCE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
FRANCE: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
ITALY: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
ITALY: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
ITALY: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
ITALY: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
SPAIN: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
SPAIN: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
SPAIN: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
SPAIN: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
CHINA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
CHINA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
CHINA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
CHINA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
JAPAN: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
JAPAN: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
JAPAN: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
JAPAN: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
INDIA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
INDIA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
INDIA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
INDIA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
BRAZIL: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
BRAZIL: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
BRAZIL: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
BRAZIL: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
MEXICO: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
MEXICO: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
MEXICO: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
MEXICO: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025
 
 
 
 
 
 
TABLE 285
MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 286
REGIONAL FOOTPRINT, 2025
 
 
 
 
 
 
TABLE 287
PRODUCT FOOTPRINT, 2025
 
 
 
 
 
 
TABLE 288
TECHNOLOGY FOOTPRINT
 
 
 
 
 
 
TABLE 289
END USER FOOTPRINT, 2025
 
 
 
 
 
 
TABLE 290
LIST OF STARTUPS/SMES, 2025
 
 
 
 
 
 
TABLE 291
MICROBIOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2), 2025
 
 
 
 
 
 
TABLE 292
MICROBIOLOGY TESTING MARKET COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2), 2025
 
 
 
 
 
 
TABLE 293
MICROBIOLOGY TESTING MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–DECEMBER 2025
 
 
 
 
 
 
TABLE 294
MICROBIOLOGY TESTING MARKET: DEALS, JANUARY 2022–DECEMBER 2025
 
 
 
 
 
 
TABLE 295
MICROBIOLOGY TESTING MARKET: EXPANSION, JANUARY 2022–DECEMBER 2025
 
 
 
 
 
 
TABLE 296
BIOMÉRIEUX: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 297
BIOMÉRIEUX: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 298
BIOMÉRIEUX: PRODUCT LAUNCHES AND APPROVALS
 
 
 
 
 
 
TABLE 299
BIOMÉRIEUX: DEALS
 
 
 
 
 
 
TABLE 300
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 301
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 302
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS
 
 
 
 
 
 
TABLE 303
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 304
MERCK KGAA: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 305
MERCK KGAA: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 306
MERCK KGAA: DEALS
 
 
 
 
 
 
TABLE 307
MERCK KGAA: EXPANSIONS
 
 
 
 
 
 
TABLE 308
BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 309
BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 310
BECKTON, DICKINSON AND COMPANY: EXPANSIONS
 
 
 
 
 
 
TABLE 311
NEOGEN CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 312
NEOGEN CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 313
NEOGEN CORPORATION: PRODUCT/SERVICE LAUNCHES
 
 
 
 
 
 
TABLE 314
NEOGEN CORPORATION: DEALS
 
 
 
 
 
 
TABLE 315
QIAGEN: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 316
MCKESSON CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 317
QIAGEN N.V.: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 318
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 319
BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 320
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 321
BRUKER: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 322
BRUKER: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 323
BRUKER: DEALS
 
 
 
 
 
 
TABLE 324
SHIMADZU CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 325
SHIMADZU CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 326
SHIMADZU CORPORATION: PRODUCT/SERVICE LAUNCHES AND APPROVALS
 
 
 
 
 
 
TABLE 327
SHIMADZU CORPORATION: EXPANSIONS
 
 
 
 
 
 
TABLE 328
CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 329
CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 330
CHARLES RIVER LABORATORIES: PRODUCT/SERVICE LAUNCHES
 
 
 
 
 
 
TABLE 331
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 332
EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 333
EUROFINS SCIENTIFIC: DEALS
 
 
 
 
 
 
TABLE 334
IDEXX: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 335
IDEXX: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 336
IDEXX: PRODUCT/SERVICE LAUNCHES AND APPROVALS
 
 
 
 
 
 
TABLE 337
HARDY DIAGNOSTICS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 338
CHARM SCIENCES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 339
MICROBIOLOGICS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 340
LIOFILCHEM S.R.L. : COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 341
R-BIOPHARM: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 342
ROMER LABS DIVISION HOLDING: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 343
HYGIENA LLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 344
HIMEDIA LABORATORIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 345
CONDALAB: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 346
E&O LABORATORIES LTD: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 347
MAST GROUP LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 348
MEDICAL WIRE & EQUIPMENT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 349
HACH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 350
MICROBIOLOGY TESTING MARKET: KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
TABLE 351
RISK ASSESSMENT
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
MICROBIOLOGY TESTING MARKET SEGMENTATION
 
 
 
 
 
 
FIGURE 2
KEY INSIGHTS AND MARKET HIGHLIGHTS
 
 
 
 
 
 
FIGURE 3
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MICROBIOLOGY TESTING MARKET, 2022–2025
 
 
 
 
 
 
FIGURE 4
DISRUPTIVE TRENDS IMPACTING GROWTH OF MICROBIOLOGY TESTING MARKET
 
 
 
 
 
 
FIGURE 5
FASTEST-GROWTH SEGMENTS AND EMERGING FRONTIERS IN MICROBIOLOGY TESTING MARKET
 
 
 
 
 
 
FIGURE 6
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 7
GROWING NEED FOR CONTAMINATION CONTROL TO DRIVE MARKET
 
 
 
 
 
 
FIGURE 8
REAGENT & KITS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 9
TRADITIONAL MICROBIOLOGY METHODS (TMM) TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 10
BACTERIAL TESTING TO CONTINUE LEAD SIGNIFICANTLY DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 11
PHARMACEUTICAL & BIOTECH COMPANIES TO COMMAND LARGEST SHARE AMONG END USERS DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 12
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 13
MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 14
PRODUCTS RECALLED GLOBALLY, 2012–2022
 
 
 
 
 
 
FIGURE 15
MICROBIOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 16
MICROBIOLOGY TESTING MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 17
MICROBIOLOGY TESTING MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 18
MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 19
MICROBIOLOGY TESTING MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
FIGURE 20
NUMBER OF DEALS & FUNDING ACTIVITIES IN MICROBIOLOGY TESTING MARKET
 
 
 
 
 
 
FIGURE 21
PATENT ANALYSIS FOR MICROBIOLOGY TESTING, JANUARY 2016–DECEMBER 2025
 
 
 
 
 
 
FIGURE 22
MARKET POTENTIAL OF AI IN MICROBIOLOGY TESTING MARKET
 
 
 
 
 
 
FIGURE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
 
 
 
 
 
 
FIGURE 24
KEY BUYING CRITERIA, BY PRODUCT
 
 
 
 
 
 
FIGURE 25
NORTH AMERICA: MICROBIOLOGY TESTING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 26
ASIA PACIFIC: MICROBIOLOGY TESTING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 27
REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION)
 
 
 
 
 
 
FIGURE 28
MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
 
 
 
 
 
 
FIGURE 29
US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
 
 
 
 
 
 
FIGURE 30
COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 31
COMPANY FOOTPRINT, 2025
 
 
 
 
 
 
FIGURE 32
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 33
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS, 2025
 
 
 
 
 
 
FIGURE 34
EV/EBITDA OF KEY VENDORS, 2025
 
 
 
 
 
 
FIGURE 35
BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
 
 
FIGURE 36
BIOMÉRIEUX: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 37
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 38
MERCK KGAA: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 39
BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 40
NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 41
QIAGEN: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 42
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 43
BRUKER: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 44
SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 45
CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 46
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 47
IDEXX: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 48
MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY
 
 
 
 
 
 
FIGURE 49
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
 
FIGURE 50
PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 51
INSIGHTS FROM INDUSTRY EXPERTS
 
 
 
 
 
 
FIGURE 52
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
 
 
 
 
 
 
FIGURE 53
BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 54
BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
 
 
 
 
 
 
FIGURE 55
CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
 
 
 
 
 
 
FIGURE 56
MICROBIOLOGY TESTING MARKET: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 57
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 
FIGURE 58
MICROBIOLOGY TESTING MARKET: RESEARCH ASSUMPTIONS
 
 
 
 
 
 

Methodology

The objective of the study is to analyze the key market dynamics of the microbiology testing sector, including drivers, opportunities, restraints, challenges, and key player strategies. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. The competitive landscape is evaluated to assess market players across various parameters within the broad categories of business and product strategy. The market size is estimated using top-down and bottom-up approaches, while market breakdown and data triangulation methods are employed to determine segment and subsegment sizes.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources included industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of the industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

Microbiology Testing Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both the top-down and bottom-up approaches have been used to estimate and validate the size of the small satellite market.

The top-down and bottom-up approaches were used to estimate and validate the total size of the microbiology testing market. These methods were also widely used to estimate the sizes of various market segments. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research.
  • The revenues generated by leading players operating in the microbiology testing industry have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Microbiology Testing Market : Top-Down and Bottom-Up Approach

Microbiology Testing Market Top Down and Bottom Up Approach

Data Triangulation

After determining the overall market size using the above-mentioned process, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides.

Market Definition

Microbiology testing involves the identification, quantification, and analysis of microorganisms, including bacteria, viruses, fungi, and protozoa, and plays a critical role in ensuring product safety, protecting public health, and preserving environmental integrity. These tests are widely used across pharmaceutical and biotech companies, food and beverage companies, environmental and water testing, cosmetics and personal-care companies, the agriculture and animal feed industry, and academic and research institutes, where they support quality control, regulatory compliance, contamination monitoring, and scientific research activities.

Key Stakeholders

  • Manufacturers & distributors of microbiology testing solutions
  • Food & beverage companies
  • Environmental and water testing organizations
  • Pharmaceutical & biotechnology companies
  • Cosmetics & personal care companies
  • Agriculture & animal feed industry
  • Contract testing laboratories
  • Academic & research institutes
  • Government and regulatory bodies
  • Market research & consulting firms
  • Venture capitalists & investors

Report Objectives

  • To define, segment, and forecast the global microbiology testing market by product, technology, pathogen type, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall microbiology testing market 
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
  • To benchmark players within the microbiology testing market using the company evaluation matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Available customizations:

MarketsandMarkets offers the following customizations for this market report.

Company Profiles

  • An additional five company profiles of players operating in microbiology testing.

Regional Analysis

  • Further breakdown of the market segments at the country level

Country Information

  • Additional country-level analysis of microbiology testing

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Microbiology Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Microbiology Testing Market

DMCA.com Protection Status